drugset / Trial / NCT05715671

Effect of Subanesthetic Dose of Esketamine on Sleep Quality and Recovery of Gastrointestinal Function in Patients Undergoing General Anesthesia Laparoscopic Uterine Surgery in the Early Postoperative Period

NCT05715671

Completed 138 enrolled Zhuan Zhang
RandomizedParallel-groupTriple-blindOther

Summary

Patients undergoing gynecological surgery are at high risk of developing postoperative sleep disorders. Intraoperative opioid use is detrimental to the patient's postoperative recovery of gastrointestinal function. Esketamine has sedative, hypnotic, analgesic, inflammatory response suppression, and antidepressant effects. Its hypnotic mechanism may be related to its rapid blockade of NMDA receptors and hyperpolarization-activated cyclic nucleotide-gated cation channels. Also can reduce the application of perioperative opioids, which in turn promotes the recovery of gastrointestinal function in patients after surgery.

Timeline

Start
2023-03-25
Primary completion
2023-11-30
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 0.15 mg/kg
Subject Esketamine Other / unclassified 0.3 mg/kg

Indications

No indication recorded.